Search Results - "Kiranmayi, Malapaka"
-
1
Functional Gly297Ser Variant of the Physiological Dysglycemic Peptide Pancreastatin Is a Novel Risk Factor for Cardiometabolic Disorders
Published in Diabetes (New York, N.Y.) (01-03-2022)“…Pancreastatin (PST), a chromogranin A-derived potent physiological dysglycemic peptide, regulates glucose/insulin homeostasis. We have identified a…”
Get full text
Journal Article -
2
Catestatin Gly364Ser Variant Alters Systemic Blood Pressure and the Risk for Hypertension in Human Populations via Endothelial Nitric Oxide Pathway
Published in Hypertension (Dallas, Tex. 1979) (01-08-2016)“…Catestatin (CST), an endogenous antihypertensive/antiadrenergic peptide, is a novel regulator of cardiovascular physiology. Here, we report case–control…”
Get full text
Journal Article -
3
A haplotype variant of the human chromogranin A gene (CHGA) promoter increases CHGA expression and the risk for cardiometabolic disorders
Published in The Journal of biological chemistry (25-08-2017)“…The acidic glycoprotein chromogranin A (CHGA) is co-stored/co-secreted with catecholamines and crucial for secretory vesicle biogenesis in…”
Get full text
Journal Article -
4
CATESTATIN GLY364SER VARIANT ALTERS SYSTEMIC BLOOD PRESSURE AND THE RISK FOR HYPERTENSION IN HUMAN POPULATIONS VIA ENDOTHELIAL NO PATHWAY
Published in Hypertension (Dallas, Tex. 1979) (20-06-2016)“…Catestatin (CST), an endogenous anti-hypertensive/anti-adrenergic peptide, is a novel regulator of cardiovascular physiology. Here, we report case-control…”
Get full text
Journal Article